(Q45036677)

8 December 2017

title

Oseltamivir-resistant influenza? (English)

1 reference

8 December 2017

1 reference

1

0 references

language of work or name

English

0 references

publication date

1 August 2004

1 reference

8 December 2017

1 reference

8 December 2017

volume

364

1 reference

8 December 2017

issue

9436

1 reference

8 December 2017

page(s)

733-734

1 reference

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Low incidence of rimantadine resistance in field isolates of influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Oral oseltamivir treatment of influenza in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Resistance of influenza viruses to neuraminidase inhibitors--a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916947-X

7 January 2021

10.1016/S0140-6736(04)16947-X

Identifiers

DOI

1 reference

8 December 2017

1 reference